Pacific Medical Center-First Hill

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Childhood cancers2 trials
• Colorectal cancer2 trials
• Chronic myeloid leukaemia1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Lung cancer1 trial
• Melanoma1 trial
• Myelodysplastic syndromes1 trial
• Neuroendocrine tumours1 trial

Phase

• Phase 37 trials

Status

• Active, not recruiting5 trials
• Completed2 trials

Lead sponsor

• National Cancer Institute (NCI)5 trials
• SWOG Cancer Research Network2 trials

Running trials

• Active, not recruiting

  S0820, Adenoma and Second Primary Prevention Trial

  NCT01349881· Phase 3· SWOG Cancer Research Network· Source

• Active, not recruiting

  Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

  NCT01274338· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

  NCT00843882· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT00588770· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

  NCT00569127· Phase 3· National Cancer Institute (NCI)· Source

Closed trials

• Completed

  S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  NCT01120249· Phase 3· SWOG Cancer Research Network· Source

• Completed

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· Phase 3· National Cancer Institute (NCI)· Source